Comment on: Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.

Authors :: Lanzafame M
Lattuada E
Corsini F
Source :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2009 Jul; Vol. 64 (1), pp. 215-6; author reply 216. Date of Electronic Publication: 2009 Mar 24.
Publication Year :: 2009

Subjects :: Furans
Humans
Anti-HIV Agents therapeutic use
Carbamates therapeutic use
HIV Infections complications
HIV Infections drug therapy
Hepatitis C, Chronic complications
Liver Cirrhosis complications
Organophosphates therapeutic use
Sulfonamides therapeutic use

Full Text Access

Tools